Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
Background. There have been many reports on des-γ-carboxy prothrombin (DCP) as a promising serum marker in the diagnosis of hepatocellular carcinoma (HCC); however, the results are inconsistent and even conflicting. Methods. This meta-analysis was performed to investigate the performance of DCP in t...
Main Authors: | Rong Zhu, Jing Yang, Ling Xu, Weiqi Dai, Fan Wang, Miao Shen, Yan Zhang, Huawei Zhang, Kan Chen, Ping Cheng, Chengfen Wang, Yuanyuan Zheng, Jingjing Li, Jie Lu, Yingqun Zhou, Dong Wu, Chuanyong Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2014/529314 |
Similar Items
-
DIAGNOSTIC ROLE OF SERUM DES-γ-CARBOXY PROTHROMBIN AND GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
by: Po-Heng Chuang, et al.
Published: (2007) -
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis.
by: Ming Yang, et al.
Published: (2019-01-01) -
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
by: Lee Yong Kang, et al.
Published: (2013-01-01) -
Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells
by: Yu-Sheng Zhang, et al.
Published: (2015-01-01) -
Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
by: Yu-Sheng Zhang, et al.
Published: (2014-08-01)